Relationship Between Depression Symptoms and Different Types of Measures of Obesity (BMI, SAD) in US Women

Overview

Journal Behav Neurol

Publisher Wiley

Specialty Psychiatry

Date 2020 Dec 10

PMID 33299495

Citations 5

Authors

Yang Zhou

Guifang Yang

Wen Peng

Hongliang Zhang

Zhenyu Peng

Ning Ding

Tao Guo

Yuzhong Cai

Qijian Deng

Xiangping Chai

Affiliations

Soon will be listed here.

Abstract

Objective: To estimate the relationship between obesity (defined by both BMI and SAD) and various levels of depressive symptoms in women in the United States.

Methods: This is a cross-sectional design. All data were collected from NHANES 2011-2012 and 2013-2014. The Patient Health Questionnaire (PHQ-9) was the primary variable used to index depressive symptoms. SAD was assessed using an abdominal caliper. We stratified participates into three groups according to SAD (trisection): T1: low (11.8-18.4 cm), T2: middle (18.5-22.8 cm), and T3: high (22.9-40.1 cm). Other data were collected following the NHANES protocols. We aimed to investigate the effects of obesity on the depression in the NHANES populations.

Results: A total of 4477 women were enrolled in the final study population. Participants with a high SAD had the highest risk of clinical depression symptoms (OR = 1.2, 95% CI: 1.1-1.4), which was, in particular, the case for moderate-severe depression (OR = 1.4, 95% CI: 1.1-1.7) and severe depression (OR = 1.4, 95% CI: 1.0-1.9). We also found a significant relationship between SAD and BMI ( = 0.836). We did, however, not find a significant relationship between BMI and severe depression.

Conclusions: SAD had a better correlation with clinical depression symptoms than BMI, especially regarding severe depression symptoms.

Citing Articles

Association between weight-adjusted waist index and overactive bladder syndrome among adult women in the United States: a cross-sectional study.

Shang Y, Chen J, Tai Y BMC Womens Health. 2024; 24(1):488.

PMID: 39232696 PMC: 11373401. DOI: 10.1186/s12905-024-03339-x.

Obesity and lipid indices as predictors of depressive symptoms in middle-aged and elderly Chinese: insights from a nationwide cohort study.

Zhang X, Wang Y, Yang X, Li Y, Gui J, Mei Y BMC Psychiatry. 2024; 24(1):351.

PMID: 38730360 PMC: 11088055. DOI: 10.1186/s12888-024-05806-z.

Association between weight-adjusted-waist index and depression: a cross-sectional study.

Fei S, Liu M, Shanshan H, Xie R, Danni W, Ningying Z Endocr Connect. 2024; 13(6).

PMID: 38657652 PMC: 11227061. DOI: 10.1530/EC-23-0450.

A Prediction Model of the Incidence of Type 2 Diabetes in Individuals with Abdominal Obesity: Insights from the General Population.

Tan C, Li B, Xiao L, Zhang Y, Su Y, Ding N Diabetes Metab Syndr Obes. 2022; 15:3555-3564.

PMID: 36411787 PMC: 9675349. DOI: 10.2147/DMSO.S386687.

Visceral Adiposity Index Is a Measure of the Likelihood of Developing Depression Among Adults in the United States.

Lei J, Luo Y, Xie Y, Wang X Front Psychol. 2022; 13:772556.

PMID: 35401344 PMC: 8991090. DOI: 10.3389/fpsyg.2022.772556.

References

Zhao K, Zhou S, Shi X, Chen J, Zhang Y, Fan K . Potential metabolic monitoring indicators of suicide attempts in first episode and drug naive young patients with major depressive disorder: a cross-sectional study. BMC Psychiatry. 2020; 20(1):387. PMC: 7389868. DOI: 10.1186/s12888-020-02791-x. View

Heo M, Pietrobelli A, Fontaine K, Sirey J, Faith M . Depressive mood and obesity in US adults: comparison and moderation by sex, age, and race. Int J Obes (Lond). 2005; 30(3):513-9. DOI: 10.1038/sj.ijo.0803122. View

Staiano A, Marker A, Martin C, Katzmarzyk P . Physical activity, mental health, and weight gain in a longitudinal observational cohort of nonobese young adults. Obesity (Silver Spring). 2016; 24(9):1969-75. PMC: 5308059. DOI: 10.1002/oby.21567. View

Jackson S, Smith L, Firth J, Grabovac I, Soysal P, Koyanagi A . Is there a relationship between chocolate consumption and symptoms of depression? A cross-sectional survey of 13,626 US adults. Depress Anxiety. 2019; 36(10):987-995. DOI: 10.1002/da.22950. View

Xiao H, Bao Y, Liu M, Yang J, Li Y, Wang Y . Sagittal abdominal diameter and Framingham risk score in non-dialysis chronic kidney disease patients. Int Urol Nephrol. 2018; 50(9):1679-1685. DOI: 10.1007/s11255-018-1861-6. View

Shah R, Murthy V, Abbasi S, Blankstein R, Kwong R, Goldfine A . Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study. JACC Cardiovasc Imaging. 2014; 7(12):1221-35. PMC: 4268163. DOI: 10.1016/j.jcmg.2014.07.017. View

Tanaka R, Nolan R . Psychobehavioral Profiles to Assist Tailoring of Interventions for Patients With Hypertension: Latent Profile Analysis. J Med Internet Res. 2018; 20(5):e149. PMC: 5970280. DOI: 10.2196/jmir.8757. View

Everson-Rose S, Lewis T, Karavolos K, Dugan S, Wesley D, Powell L . Depressive symptoms and increased visceral fat in middle-aged women. Psychosom Med. 2009; 71(4):410-6. PMC: 2739059. DOI: 10.1097/PSY.0b013e3181a20c9c. View

Ali M, Chwastiak L, Poongothai S, Emmert-Fees K, Patel S, Anjana R . Effect of a Collaborative Care Model on Depressive Symptoms and Glycated Hemoglobin, Blood Pressure, and Serum Cholesterol Among Patients With Depression and Diabetes in India: The INDEPENDENT Randomized Clinical Trial. JAMA. 2020; 324(7):651-662. PMC: 7435347. DOI: 10.1001/jama.2020.11747. View

10.

McLean C, Asnaani A, Litz B, Hofmann S . Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness. J Psychiatr Res. 2011; 45(8):1027-35. PMC: 3135672. DOI: 10.1016/j.jpsychires.2011.03.006. View

11.

Vogelzangs N, Kritchevsky S, Beekman A, Newman A, Satterfield S, Simonsick E . Depressive symptoms and change in abdominal obesity in older persons. Arch Gen Psychiatry. 2008; 65(12):1386-93. PMC: 3285453. DOI: 10.1001/archpsyc.65.12.1386. View

12.

Linde J, Simon G, Ludman E, Ichikawa L, Operskalski B, Arterburn D . A randomized controlled trial of behavioral weight loss treatment versus combined weight loss/depression treatment among women with comorbid obesity and depression. Ann Behav Med. 2010; 41(1):119-30. PMC: 3033656. DOI: 10.1007/s12160-010-9232-2. View

13.

Zhang J, Yao W, Ren Q, Yang C, Dong C, Ma M . Depression-like phenotype by deletion of α7 nicotinic acetylcholine receptor: Role of BDNF-TrkB in nucleus accumbens. Sci Rep. 2016; 6:36705. PMC: 5099687. DOI: 10.1038/srep36705. View

14.

Haynes A, Kersbergen I, Sutin A, Daly M, Robinson E . Does perceived overweight increase risk of depressive symptoms and suicidality beyond objective weight status? A systematic review and meta-analysis. Clin Psychol Rev. 2019; 73:101753. DOI: 10.1016/j.cpr.2019.101753. View

15.

Rivenes A, Harvey S, Mykletun A . The relationship between abdominal fat, obesity, and common mental disorders: results from the HUNT study. J Psychosom Res. 2009; 66(4):269-75. DOI: 10.1016/j.jpsychores.2008.07.012. View

16.

Xing Z, Pei J, Huang J, Peng X, Chen P, Hu X . Relationship of Obesity to Adverse Events Among Patients With Mean 10-Year History of Type 2 Diabetes Mellitus: Results of the ACCORD Study. J Am Heart Assoc. 2018; 7(22):e010512. PMC: 6404442. DOI: 10.1161/JAHA.118.010512. View

17.

Penninx B, Milaneschi Y, Lamers F, Vogelzangs N . Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Med. 2013; 11:129. PMC: 3661358. DOI: 10.1186/1741-7015-11-129. View

18.

Patel J, Oh Y, Rand K, Wu W, Cyders M, Kroenke K . Measurement invariance of the patient health questionnaire-9 (PHQ-9) depression screener in U.S. adults across sex, race/ethnicity, and education level: NHANES 2005-2016. Depress Anxiety. 2019; 36(9):813-823. PMC: 6736700. DOI: 10.1002/da.22940. View

19.

Lasselin J, Capuron L . Chronic low-grade inflammation in metabolic disorders: relevance for behavioral symptoms. Neuroimmunomodulation. 2014; 21(2-3):95-101. DOI: 10.1159/000356535. View

20.

Ahmadi S, Filipsson K, Dimenas H, Isaksson S, Imberg H, Sjoberg S . Effect of liraglutide on anthropometric measurements, sagittal abdominal diameter and adiponectin levels in people with type 2 diabetes treated with multiple daily insulin injections: evaluations from a randomized trial (MDI-liraglutide study 5). Obes Sci Pract. 2019; 5(2):130-140. PMC: 6469338. DOI: 10.1002/osp4.324. View